{
    "clinical_study": {
        "@rank": "63957", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate clinical safety issues pertaining to lisuride, to\n      cocaine, and to its interaction in a chronic, crack dependent population, and to determine\n      how pretreatment with lisuride modifies the subjective as well as physiological effects of\n      cocaine."
        }, 
        "brief_title": "Infusion Laboratory: Protocol 2 (Lisuride) - 3", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the\n        study and sign informed consent.\n\n        Exclusion Criteria:\n\n        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant\n        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.\n        Acute hepatitis. Other medical condtions that deem participation to be unsafe."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "2", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000338", 
            "org_study_id": "NIDA-3-0010-3", 
            "secondary_id": "Y01-3-0010-3"
        }, 
        "intervention": {
            "intervention_name": "Lisuride", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Lisuride"
        }, 
        "lastchanged_date": "August 16, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90025"
                }, 
                "name": "Friends Research Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Infusion Laboratory: Protocol 2 (Lisuride)", 
        "overall_official": {
            "affiliation": "Friends Research Institute, Inc.", 
            "last_name": "Walter Ling, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "primary_outcome": [
            {
                "measure": "Degree of drug craving"
            }, 
            {
                "measure": "History, incidence and amount of drug use"
            }, 
            {
                "measure": "Type and severity of stimulant withdrawal symptoms"
            }, 
            {
                "measure": "Characterization of study population"
            }, 
            {
                "measure": "Population incidence of symptoms of depression, po"
            }, 
            {
                "measure": "Frequency and intensity of drug use and sexual beh"
            }, 
            {
                "measure": "Evidence of change in neurophysiology and brain ac"
            }, 
            {
                "measure": "Evidence of change in subjective responses to coca"
            }, 
            {
                "measure": "Clinical physiological response to cocaine challen"
            }, 
            {
                "measure": "Degree to which study medication influences change"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000338"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "March 1996", 
        "study_design": "Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 1996"
    }, 
    "geocoordinates": {
        "Friends Research Institute": "34.052 -118.244"
    }
}